Document 0518
 DOCN  M9490518
 TI    Human immunodeficiency virus antibody test and seroprevalence in
       psychiatric patients.
 DT    9411
 AU    Naber D; Pajonk FG; Perro C; Lohmer B; Psychiatric Hospital, University
       of Munich, Germany.
 SO    Acta Psychiatr Scand. 1994 May;89(5):358-61. Unique Identifier :
       AIDSLINE MED/94346300
 AB    Psychiatric inpatients are at risk for human immunodeficiency virus
       (HIV) infection. Investigations in the United States revealed
       seroprevalence rates of 5.5-8.9%. Therefore, inclusion of HIV antibody
       testing in routine laboratory screening is sometimes suggested. To
       investigate this issue for inpatients in the Department of Psychiatry,
       University of Munich, the incidence, reason for HIV testing and results
       were analyzed. Of 12,603 patients, hospitalized from 1985 to 1993, 4.9%
       (623 patients, 265 in risk groups) underwent the HIV test after informed
       consent. Thirty patients (4.8% of those tested) were found to be
       positive, but only in 5 cases (all of risk groups) was infection newly
       detected. Data indicate that, in psychiatry, HIV testing is reasonable
       only in patients in risk groups or if clinical variables suggest HIV
       infection.
 DE    Acquired Immunodeficiency Syndrome/COMPLICATIONS/*EPIDEMIOLOGY
       Adolescence  Adult  Aged  Aged, 80 and over  Female
       Germany/EPIDEMIOLOGY  Human  *HIV Seroprevalence  Male  Mental
       Disorders/*COMPLICATIONS  Middle Age  Risk Factors  JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).